Rotherham healthcare decontamination specialist DawMed have announced their latest financial results. Turnover increased by 67% to £3.82m compared to £2.29m in 2006 and the company said sales of its own products significantly increased over the six months up to March 31st. Without the impact of losses such as the exceptional foreign exchange rate, the company would have made a profit in the period of £61,900. Kevin Gilmore, Executive Chairman of Dawmed, commented: "I am pleased to report a buoyant period of recovery from last year's losses, with a first half underlying performance turnaround of £501,000, excluding the effects of the exceptional foreign exchange loss and the non-recurring abnormal costs expected to be recoverable in the second half, and I look forward to the current profitable trading leading to profitability for the second half of the year."
Rotherham healthcare decontamination specialist DawMed have announced their latest financial results. Turnover increased by 67% to £3.82m compared to £2.29m in 2006 and the company said sales of its own products significantly increased over the six months up to March 31st. Without the impact of losses such as the exceptional foreign exchange rate, the company would have made a profit in the period of £61,900. Kevin Gilmore, Executive Chairman of Dawmed, commented: "I am pleased to report a buoyant period of recovery from last year's losses, with a first half underlying performance turnaround of £501,000, excluding the effects of the exceptional foreign exchange loss and the non-recurring abnormal costs expected to be recoverable in the second half, and I look forward to the current profitable trading leading to profitability for the second half of the year."
Rotherham
0 comments:
Post a Comment